Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory Tecvayli: New Drug for Multiple Myeloma August 24, 2022September 8, 2022 Teclistamab by Johnson & Johnson is a new hope for refractory or relapsing multiple myeloma.
